西部数智院自2024年成立以来，已见刊或接收的SCI论文近20篇，其中IF≥10有5篇，最高IF=18。

1.Dong, X., Xiang, H., Li, J., Hao, A., Wang, H., Gou, Y., Li, A., Rahaman, S., Qiu, Y., Li, J., Mei, O.., Zhong, J., You, W., Shen, G., Wu, X., Li, J., Shu, Y.,Shi, L., Zhu, Y., Reid R ., He, T., Fan, J. (2025). Dermal fibroblast-derived extracellular matrix (ECM) synergizes with keratinocytes in promoting re-epithelization and scarless healing of skin wounds: Towards optimized skin tissue engineering. Bioactive Materials. (IF=18, Accepted)

2.Shen, S., Wang, W., Ma, Y., Wang, S., Zhang, S., Cai, X., Chen, L., Zhang, J., Li, Y., Wu, X., Wei, J., Zhao, Y., Huang, A., Niu, S., & Wang, D. (2024). Affinity molecular assay for detecting Candida albicans using chitin affinity and RPA-CRISPR/Cas12a. Nature communications, 15(1), 9304. (IF=14.7)

3.Li, Y., Duan, Z., Li, Z., & Xue, W. (2025). Data and AI-driven synthetic binding protein discovery. Trends in pharmacological sciences, S0165-6147(24)00268-2. Advance online publication. (IF=13.9)

4.Ren, K., Zhang, B., Guo, J., Cao, H., Cheng, J., Guo, J., & Li, D. (2025). Aggregation-induced emission(AIE)for next-generation biosensing and imaging: A review. Biosensors & bioelectronics, 271, 117067. (IF=10.7)

5.Wu, K., He, M., Mao, B., Xing, Y., Wei, S., Jiang, D., Wang, S., Alkuhali, A. A., Guo, J., Gan, Z., Li, M., Li, X., & Chen, H. (2024). Enhanced delivery of CRISPR/Cas9 system based on biomimetic nanoparticles for hepatitis B virus therapy. Journal of controlled release , 374, 293–311. (IF=10.5)

6.Wei, C., He, J., Wen, J., Wang, S., Shi, M., Hu, J., Tan, H., Guo, J., Li,X. (2025) Genetically Predicted Blood Metabolites Mediates the Association between Immune Cell Characteristics and Urolithiasis: A Mendelian Randomiz,ation Study and Mediation Analysis. GENES DIS. (IF=6.9, Accepted)

7.Chi, H., Jiang, L., Zhou, X., Wang, L., Yang, G., Luo, H., Liu, X., Xu, K., & Tian, G. (2024). Editorial: Immune cell exhaustion: new challenges and opportunities in cancer therapy. Frontiers in immunology, 15, 1527428. (IF=5.7)

8.Khan, M. N., Mao, B., Hu, J., Shi, M., Wang, S., Rehman, A. U., & Li, X. (2024). Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC. Frontiers in immunology, 15, 1472430. (IF=5.7)

9.Chi, H., Jiang, L., Zhou, X., Huang, G., Luo, H., Xu, K., & Li, X. (2024). Editorial: Immunological characteristics and novel therapeutic targets for metastatic gastrointestinal tumors. Frontiers in immunology, 15, 1476405. (IF=5.7)

10.Wu, X., Xiang, R., Yang, D., He, X., Zhu, L., Sun, F., Li, H., Pi, N., & Li, Y. (2024). HRP-integrated CRISPR-Cas12a biosensor for rapid point-of-care detection of Langya henipavirus. iScience, 27(12), 111466. (IF=4.6)

11.Deng, Y., Shi, M., Yi, L., Naveed Khan, M., Xia, Z., & Li, X. (2024). Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment. Heliyon, 10(17), e37060. (IF=3.4)

12.Su, K., Li, J., Liu, H., & Zou, Y. (2024). Emerging Trends in Integrated Digital Microfluidic Platforms for Next-Generation Immunoassays. Micromachines, 15(11), 1358. (IF=3.0)

13.Yu, B., Li, Q., Zhang, W., Xiang, X., Quda, D., Zhuoga, G., Huang, Q., Cheng, J., Guo, J., Liu, Z., & Shi, L. (2024). Development and clinical validation of photochemical biosensors for monitoring hemoglobin, blood lipids and uric acid in plateau areas. Analytical methods: advancing methods and applications, 10.1039/d4ay01737d. Advance online publication. (IF=2.7)

14.Chen, Y., Yan, H., Xu, Y., Chen, K., Yang, R., Yang, J., Zhu, R., Lin, R., Wang, J., Liu, J., Gao, P., Pang, L., & Wang, L. (2025). Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer. Discover oncology, 16(1), 13. (IF=2.8)